Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction

Withdrawn before enrolling · Phase 4

Conditions studied: Hernia, Ventral

In brief

The aim of this study is to evaluate the short-term postoperative outcomes in the abdominal wall reconstruction population using an intraoperative local anesthetic infusion. A prospective randomized double blind study of patients undergoing component separation will be performed in order to assess the following outcomes: 1. Length of Stay (LOS) 2. Return of bowel function 3. Narcotic pain medication requirements 4. Nausea and emesis 5. Pain scores

Key facts

Study ID

NCT02274077

Run by

Chester Mays

People needed

0

Starts

2016-01-01

Expected to finish

2017-06-01

Last updated by the study team

2016-07-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects to be included are all competent patients, 18 years of age or older, who undergo abdominal component separation for a hernia.

You may not qualify if…

• Patients who are not having abdominal component separation or are receiving another form of regional anesthesia will be excluded.
• Patients younger than 18 years of age will be excluded.
• Amide-type local anesthetics, such as bupivacaine, are metabolized by the liver.
• Patients' with hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations and will therefore be excluded from the study.

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.